The share of corresponding/leading authors in scientific publications within endocrinology, diabetes, and metabolism in the UK shows a decreasing trend, starting from 84.5% in 2024 and forecasted to decline to 82.92% by 2028. Historically, the value stood at 85% in 2023, indicating a year-on-year reduction. From 2024 to 2028, there is an expected compound annual growth rate (CAGR) decline of approximately 0.47% per year.

Future trends to monitor:

Impact of collaborative research initiatives on author roles.
Shifts in publication authorship norms globally and their influence on the UK.
Potential effects of policy changes on research funding and publication practices.